[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2003212246A1 - Method for diagnosis of inflammatory diseases using mrp8/mrp14 - Google Patents

Method for diagnosis of inflammatory diseases using mrp8/mrp14

Info

Publication number
AU2003212246A1
AU2003212246A1 AU2003212246A AU2003212246A AU2003212246A1 AU 2003212246 A1 AU2003212246 A1 AU 2003212246A1 AU 2003212246 A AU2003212246 A AU 2003212246A AU 2003212246 A AU2003212246 A AU 2003212246A AU 2003212246 A1 AU2003212246 A1 AU 2003212246A1
Authority
AU
Australia
Prior art keywords
mrp14
mrp8
diagnosis
inflammatory diseases
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003212246A
Other versions
AU2003212246A8 (en
Inventor
Johannes Roth
Clemens Sorg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2003212246A1 publication Critical patent/AU2003212246A1/en
Publication of AU2003212246A8 publication Critical patent/AU2003212246A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4727—Calcium binding proteins, e.g. calmodulin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2003212246A 2002-02-15 2003-02-17 Method for diagnosis of inflammatory diseases using mrp8/mrp14 Abandoned AU2003212246A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7748602A 2002-02-15 2002-02-15
US10/077,486 2002-02-15
PCT/EP2003/001576 WO2003069349A2 (en) 2002-02-15 2003-02-17 Method for diagnosis of inflammatory diseases using mrp8/mrp14

Publications (2)

Publication Number Publication Date
AU2003212246A1 true AU2003212246A1 (en) 2003-09-04
AU2003212246A8 AU2003212246A8 (en) 2003-09-04

Family

ID=27732668

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003212246A Abandoned AU2003212246A1 (en) 2002-02-15 2003-02-17 Method for diagnosis of inflammatory diseases using mrp8/mrp14

Country Status (2)

Country Link
AU (1) AU2003212246A1 (en)
WO (1) WO2003069349A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070123455A1 (en) * 2003-04-04 2007-05-31 Joel Palefsky Immunomodulatory agents for treatment of inflammatory diseases
FR2841786A1 (en) * 2003-06-13 2004-01-09 Biomerieux Stelhys Use of specific polypeptides of the calgranulin B family for diagnosis and therapy of degenerative, neurological or autoimmune diseases, especially multiple sclerosis
US7659087B2 (en) 2004-07-23 2010-02-09 Aspenbio Pharma, Inc. Methods and devices for diagnosis of appendicitis
MX2007000956A (en) 2004-07-23 2007-06-05 Aspenbio Pharma Inc Methods and devices for diagnosis of appendicitis.
WO2006122723A1 (en) * 2005-05-19 2006-11-23 Vaecgene Biotech Gmbh Method for the prevention and/or treatment of autoimmune disease or allogeneic transplant rejections
FR2941240B1 (en) * 2009-01-19 2013-05-10 Biomerieux Sa METHOD FOR DETERMINING THE SENSITIVITY OF A PATIENT TO CONTRACT A NOSOCOMIAL INFECTION
FR2941239B1 (en) * 2009-01-19 2013-11-15 Biomerieux Sa METHOD FOR DETERMINING THE SUSCEPTIBILITY TO CONTRACT NOSOCOMIAL INFECTION IN A PATIENT WITH AN INFLAMMATORY SYSTEMIC RESPONSE ASSOCIATED WITH OR NOT ASSOCIATED WITH INFECTION
KR20180026561A (en) 2009-01-19 2018-03-12 비오메리으 Methods for determining the likelihood of a patient contracting a nosocomial infection and for determining the prognosis of the course of a septic syndrome
US20130052665A1 (en) * 2011-08-25 2013-02-28 Bruce Xuefeng Ling Methods for diagnosis of systemic juvenile idiopathic arthritis
WO2015085311A1 (en) * 2013-12-07 2015-06-11 Case Western Reserve University Compositions and methods of treating thrombosis
TWI704349B (en) * 2019-06-17 2020-09-11 高雄榮民總醫院 Use of protein biomarker for diagnosing kawasaki disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3789413T2 (en) * 1986-10-03 1994-07-28 Ciba Geigy Ag Lymphokine-like peptides.
AU2002304710A1 (en) * 2001-04-30 2002-11-11 Switch Biotech Ag Mrp8/mrp14 heterodimer, or its individual components in combination, for treating and/or preventing skin diseases, wounds and/or wound-healing disturbances

Also Published As

Publication number Publication date
WO2003069349A3 (en) 2004-02-05
WO2003069349A2 (en) 2003-08-21
AU2003212246A8 (en) 2003-09-04

Similar Documents

Publication Publication Date Title
AU2003219689A1 (en) Method and system for risk-modulated diagnosis of disease
AU2003301347A1 (en) Methods for monitoring treatment of disease
AU2003253014A1 (en) Method for the diagnosis and differential diagnosis of neurological diseases
AU2003224414A1 (en) Acoustic diagnosis of sinusitis
AU2003301564A1 (en) Method for improved diagnosis of dysplasias
AU2003277289A1 (en) Method for diagnosing and interpreting dental conditions
AU2003212245A1 (en) Method of diagnosis of inflammatory diseases using calgranulin c
AU2003212246A1 (en) Method for diagnosis of inflammatory diseases using mrp8/mrp14
EP1611120A4 (en) Novel methods for the treatment of inflammatory diseases
AU2002221906A1 (en) Method for diagnosing allergic diseases
AU2002309180A1 (en) Composition and kit for the treatment of inflammatory bowel diseases
EP1708961A4 (en) Treatment of inflammatory bowel diseases with anti-ip-10 antibodies
AU2002330624A1 (en) Method of determining susceptibility to inflammatory bowel disease
AU2003218208A1 (en) Methods for diagnosis and prognosis of cancer
AU2003280824A1 (en) Method of organ regeneration
AU2003254895A1 (en) Method of judging inflammatory disease
AU2003294206A1 (en) Methods for diagnosing htlv-i-mediated diseases
AU2003283732A1 (en) Method of tomographic imaging
AU2003251650A1 (en) Screening for agents suitable for treatment of leukocyte associated inflammatory diseases
WO2004042371A1 (en) Method for quick diagnosis of kidney diseases
AU2003277600A1 (en) Method for quick diagnosis of kidney diseases
AU2003273243A1 (en) Method for treating inflammatory bowel disease
AU2003900639A0 (en) Novel method of treating inflammatory diseases
AU2003211623A1 (en) Method of measuring the activity of dna-binding protein
AU2003293517A1 (en) Methods of determining embryo viability

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase